Patents by Inventor Mohammad F. Kiani

Mohammad F. Kiani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein Kinase C-delta targeted therapy for treating radiation injury
    Publication number: 20200113979
    Abstract: The present invention provides compositions and methods for enhancing the radiation resistance of a cell by modulating PKC? and methods of preventing or treating radiation-mediated injury.
    Type: Application
    Filed: June 12, 2018
    Publication date: April 16, 2020
    Inventors: Mohammad F. Kiani, Laurie E. Kilpatrick, Yuan Tang, Fariborz Soroush
  • Compositions and methods for treatment of cancer
    Patent number: 10188728
    Abstract: Provided are compositions, methods and kits for treating cancer comprising targeted liposomes comprising a chemotherapy agent and a sensitizer for the chemotherapy agent, and non-targeted liposomes comprising an anti-angiogenic agent. In some embodiments, the targeted liposomes are immunoliposomes. In further embodiments, the immunoliposomes bind to Her-2/neu, and the composition is for treating breast cancer.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: January 29, 2019
    Assignee: Temple University—Of The Commonwealth System of Higher Education
    Inventors: Bin Wang, Mohammad F. Kiani, Yuan Tang
  • COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
    Publication number: 20150366993
    Abstract: Provided are compositions, methods and kits for treating cancer comprising targeted liposomes comprising a chemotherapy agent and a sensitizer for the chemotherapy agent, and non-targeted liposomes comprising an anti-angiogenic agent. In some embodiments, the targeted liposomes are immunoliposomes. In further embodiments, the immunoliposomes bind to Her-2/neu, and the composition is for treating breast cancer.
    Type: Application
    Filed: October 16, 2013
    Publication date: December 24, 2015
    Inventors: Bin Wang, Mohammad F. Kiani, Yuan Tang
  • COMBINED MESENCHYMAL STEM CELL TRANSPLANTATION AND TARGETED DELIVERY OF VEGF FOR TREATMENT OF MYOCARDIAL INFARCTION
    Publication number: 20140186431
    Abstract: Compositions and kits useful for the treatment of myocardial infarction comprise (i) P-selectin-targeted carriers (e.g., P-selectin-targeted liposomes, quantum dots or biodegradable nanoparticles) comprising VEGF and (ii) MSCs.
    Type: Application
    Filed: December 4, 2013
    Publication date: July 3, 2014
    Applicant: Temple University - Of The Commonwealth System of Higher Education
    Inventors: Bin Wang, Mohammad F. Kiani, Yuan Tang
  • Targeting drug/gene carriers to irradiated tissue
    Patent number: 7182933
    Abstract: The present invention provides a biomolecular carrier of pharmaceuticals, comprising: a biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell; and a pharmaceutical. The present invention also provides a method of treating a pathophysiological state in an individual in need of such treatment, comprising the steps of: irradiating a target tissue or organ in said individual; and administering to said individual the biomolecular carrier disclosed herein.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: February 27, 2007
    Assignees: The University of Tennessee Research Corporation, The Board of Trustess of Ohio University
    Inventors: Douglas J. Goetz, Mohammad F. Kiani
  • Targeting drug/gene carriers to irradiated tissue
    Publication number: 20020044959
    Abstract: The present invention provides a biomolecular carrier of pharmaceuticals, comprising: a biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell; and a pharmaceutical. The present invention also provides a method of treating a pathophysiological state in an individual in need of such treatment, comprising the steps of: irradiating a target tissue or organ in said individual; and administering to said individual the biomolecular carrier disclosed herein.
    Type: Application
    Filed: October 12, 2001
    Publication date: April 18, 2002
    Inventors: Douglas J. Goetz, Mohammad F. Kiani